טוען...
Renal Tubular Acidosis an Adverse Effect of PD-1 Inhibitor Immunotherapy
Immune checkpoint blockade therapy is gaining popularity among oncologists for treatment of solid and hematologic malignancies. The widespread use of these agents resulted in increasing incidence of renal immune-related adverse events. Reported renal toxicity described so far includes acute intersti...
שמור ב:
| הוצא לאור ב: | Case Rep Oncol Med |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5831873/ https://ncbi.nlm.nih.gov/pubmed/29666732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8408015 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|